CD8A and neoplasm: Compared to patients with high LAMP2A expression, those with low LAMP2A expression showed significantly increased tumor-infiltrating CD8+T cells and IFNγ expression, indicating a favorable response to PD-1 monoclonal antibody treatment (Figures 7A-B).